Kimberly McBennett is a Respiratory physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 31 publications with 936 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-7700Registry record last updated 9 Apr 2015.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Digestive Care, Inc.Program year20252 payments
- Aimmune Therapeutics, Inc.Program year20252 payments
- AIMMUNE THERAPEUTICS, INC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
46.2%Other respiratory system products21.6%Trikafta100%Part D≥23 patientsbeta2-Adrenergic Agonist12.5%Albuterol Sulfate Hfa82%Ventolin Hfa18%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
23.1%Antidiarrheal microorganisms11.5%Creon35%Pertzye34%Zenpep31%Part D<11 patientsProton pump inhibitor3.4%Omeprazole100%Part D<11 patients+ 5 more classes in this area
Anti-infectives
15.9%Macrolide Antimicrobial7%Azithromycin100%Part D<11 patientsPolymyxin-class Antibacterial3.4%Colistimethate100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term reductions in inflammation in people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
Annals of the American Thoracic Society
2025 - 25 Dysfunctional antigenic-induced antibody responses in cystic fibrosis
Journal of Cystic Fibrosis
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”